To celebrate the anniversary, numerous events are planned to take place around the world.
Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials.
Innovation plays an important role in overcoming global challenges and is a key driver of future growth at Bayer.
With our distinctive knowledge of people, animals, plants and materials, we intend to focus in future on the areas of health care, nutrition and high-tech materials.
Read more about our economic, ecological and social challenges and opportunities.
This area provides news, videos and publications, as well as overviews of social media channels and mobile apps of the Bayer Group.
Our service to analysts, investors and rating agencies helps increase Bayer's market capitalization and enhances our credit rating.
Looking for a job in an innovative company? Learn more about Bayer and the opportunities available.
In North America (United States and Canada), Bayer is represented in all strategic business areas. In 2012 Bayer’s 15,300 employees in this region generated sales of €9.6 billion.
North America
Sales
€ 9,576 million
Employees
15,300
Capital expenditures
€ 574 million
R&D expenses
€ 588 million
Companies
46 **
**
fully consolidated subsidiaries (as of Dec. 31, 2012)
